Insider Shareholders with Direct Ownership of Regulus Therapeutics Inc. (RGLS)
This section provides a comprehensive overview of the insiders with direct ownership of Regulus Therapeutics Inc. (RGLS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Regulus Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Growth Equity Opportunities V, Llc
> 10% Shareholder |
4,398,602 | 0 | 6,451,056 $52.6 Million | 1 |
Dec 04, 2020
Added 40.54%
|
|
Denis Drygin
Chief Scientific Officer |
100,000 | 0 | 100,000 $816,000 | 2 |
Mar 01, 2022
Added 43.4%
|
| 62,500 | 62,500 | 90,000 $734,400 | 2 |
Jun 09, 2022
Added 50.0%
|
|
| 82,110 | 84,669 | 22,169 $180,899 | 3 |
Jan 30, 2025
Added 46.94%
|
|
| 62,500 | 67,233 | 0 $0 | 2 |
Jun 25, 2025
Reduced 100.0%
|
|
| 3,550,448 | 1,040,888 | 0 $0 | 6 |
Jun 25, 2025
Reduced 100.0%
|
|
|
Joseph P Hagan
Chief Executive Officer |
536,600 | 727,616 | 0 $0 | 12 |
Jun 25, 2025
Reduced 100.0%
|
|
Christopher Ray Aker
Sr. VP & General Counsel |
95,375 | 195,588 | 0 $0 | 9 |
Jun 25, 2025
Reduced 100.0%
|
|
Crispina Calsada
Chief Financial Officer |
94,750 | 189,500 | 0 $0 | 6 |
Jun 25, 2025
Reduced 100.0%
|
|
Preston Klassen
President & Head of R & D |
79,500 | 147,000 | 0 $0 | 4 |
Jun 25, 2025
Reduced 100.0%
|
| 62,500 | 62,500 | 0 $0 | 2 |
Jun 25, 2025
Reduced 100.0%
|
|
| 62,500 | 64,271 | 0 $0 | 2 |
Jun 25, 2025
Reduced 100.0%
|
|
| 72,825 | 75,565 | 0 $0 | 5 |
Jun 25, 2025
Reduced 100.0%
|